Biora Therapeutics
(OTC) PROG
Biora Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.35M
Net Income (TTM)
$201.99M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PROG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biora Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Adi Mohanty, MBA
Website
www.bioratherapeutics.comHeadquarters
San Diego, CA 92122, US
PROG Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-16786%
Net Income Margin
-31029%
Return on Equity
1%
Return on Capital
2%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.25M
Operating Income
$234.90M
EBITDA
$164.57M
Operating Cash Flow
$167.49M
Capital Expenditure
$855.00K
Free Cash Flow
$168.34M
Cash & ST Invst.
$88.40M
Total Debt
$0.00
Biora Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$107.00K
-99.6%
Gross Profit
$107.00K
-95.3%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
124
N/A
Net Income
$11.73M
+63.6%
EBITDA
$16.93M
+38.4%
Quarterly Fundamentals
Net Cash
$62.03M
+36.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$127.83M
-21.1%
Short Term Debt
$1.43M
+186.0%
Return on Assets
-3.98%
N/A
Return on Invested Capital
2.11%
N/A
Free Cash Flow
$24.30M
+50.4%
Operating Cash Flow
$23.95M
+50.7%